Save information for later
Sign Up

Learn About Giant Congenital Melanocytic Nevus

What is the definition of Giant Congenital Melanocytic Nevus?

Giant congenital melanocytic nevus is a skin condition characterized by an abnormally dark, noncancerous skin patch (nevus) that is composed of pigment-producing cells called melanocytes. It is present from birth (congenital) or is noticeable soon after birth. The nevus may be small in infants, but it will usually grow at the same rate the body grows and will eventually be at least 40 cm (15.75 inches) across. The nevus can appear anywhere on the body, but it is more often found on the trunk or limbs. The color ranges from tan to black and can become darker or lighter over time. The surface of a nevus can be flat, rough, raised, thickened, or bumpy; the surface can vary in different regions of the nevus, and it can change over time. The skin of the nevus is often dry and prone to irritation and itching (dermatitis). Excessive hair growth (hypertrichosis) can occur within the nevus. There is often less fat tissue under the skin of the nevus; the skin may appear thinner there than over other areas of the body.

What are the causes of Giant Congenital Melanocytic Nevus?

NRAS gene mutations cause most cases of giant congenital melanocytic nevus. Rarely, mutations in the BRAF gene are responsible for this condition.

How prevalent is Giant Congenital Melanocytic Nevus?

Giant congenital melanocytic nevus occurs in approximately 1 in 20,000 newborns worldwide.

Is Giant Congenital Melanocytic Nevus an inherited disorder?

This condition is generally not inherited but arises from a mutation in the body's cells that occurs after conception. This alteration is called a somatic mutation. A somatic mutation in one copy of the NRAS or BRAF gene is sufficient to cause this disorder.

Who are the top Giant Congenital Melanocytic Nevus Local Doctors?

Kansas University Physicians Inc

3901 Rainbow Blvd, 
Kansas City, KS 
 420.6 mi
Accepting New Patients

Ting Wang-Weinman is a Dermatologist in Kansas City, Kansas. Dr. Wang-Weinman and is rated as a Distinguished provider by MediFind in the treatment of Giant Congenital Melanocytic Nevus. Her top areas of expertise are Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus. Dr. Wang-Weinman is currently accepting new patients.

15 E 11th St, 
Liberal, KS 
 53.5 mi
Accepting New Patients

Marek Kaminski is a Dermatologist in Liberal, Kansas. Dr. Kaminski and is rated as an Experienced provider by MediFind in the treatment of Giant Congenital Melanocytic Nevus. His top areas of expertise are Actinic Keratosis, Lymphocytic Vasculitis, Acrogeria, Gottron Type, and Stiff Skin Syndrome. Dr. Kaminski is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More

Dermatology And Skin Cancer Specialists LLC

7901 W 135th St, 
Overland Park, KS 
 413.6 mi
Accepting New Patients
Offers Telehealth

Jeffery Graves is a Dermatologist in Overland Park, Kansas. Dr. Graves and is rated as an Advanced provider by MediFind in the treatment of Giant Congenital Melanocytic Nevus. His top areas of expertise are Eosinophilic Pustular Folliculitis, Basal Cell Skin Cancer, Actinic Keratosis, and Seborrheic Keratosis. Dr. Graves is currently accepting new patients.

What are the latest Giant Congenital Melanocytic Nevus Clinical Trials?
Quality of Life and Experience of Stigmatization in Children with Congenital Melanocytic Nevi Before and After Nevus Excision: a Prospective Study

Summary: Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was feared. Recent data proof that the risk for malignancy was overestimated. Nowadays still a lot of patients express their wish for surgical removal out of aesthetic reasons and psychological impacts. Ma...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma (NevustoMel)

Summary: The primary objective of this study is to identify the molecular identity profiles of all cellular states that characterize the progression from benign nevi to malignant melanoma in CAYA patients with L/GCMN. The secondary objectives are: * To longitudinally characterize the cell-free DNA (cfDNA) from CAYA patients. * To improve the early diagnosis and treatments for intermediate conditions such a...

Who are the sources who wrote this article ?

Published Date: December 01, 2014
Published By: National Institutes of Health